Your browser doesn't support javascript.
loading
Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.
Tomita, Yoshihiko; Kondo, Tsunenori; Kimura, Go; Inoue, Takamitsu; Wakumoto, Yoshiaki; Yao, Masahiro; Sugiyama, Takayuki; Oya, Mototsugu; Fujii, Yasuhisa; Obara, Wataru; Motzer, Robert J; Uemura, Hirotsugu.
Afiliación
  • Tomita Y; Department of Urology, Niigata University, Niigata, Japan.
  • Kondo T; Department of Urology, Yamagata University Hospital, Yamagata, Japan.
  • Kimura G; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Inoue T; Department of Urology, Nippon Medical School Hospital, Tokyo, Japan.
  • Wakumoto Y; Department of Urology, Akita University Hospital, Akita, Japan.
  • Yao M; Department of Urology, Juntendo University Hospital, Tokyo, Japan.
  • Sugiyama T; Department of Urology, Yokohama City University Hospital, Yokohama, Japan.
  • Oya M; Department of Urology, Hamamatsu University Hospital, Hamamatsu, Japan.
  • Fujii Y; Department of Urology, Keio University Hospital, Tokyo, Japan.
  • Obara W; Department of Surgery, Urology, Tokyo Medical and Dental University Hospital, University Hospital of Medicine, Tokyo, Japan.
  • Motzer RJ; Department of Urology, Iwate Medical University Hospital, Morioka, Japan.
  • Uemura H; Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY, USA.
Jpn J Clin Oncol ; 50(1): 12-19, 2020 Jan 24.
Article en En | MEDLINE | ID: mdl-31633185

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Antineoplásicos Inmunológicos / Sunitinib / Nivolumab / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Jpn J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Antineoplásicos Inmunológicos / Sunitinib / Nivolumab / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Jpn J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Japón